SEC Form 4 · accession 0000939767-17-000159

EXELIXIS, INC. · EXEL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Gisela Schwab

Officer — Pres Prod Dev & Med Aff & CMO

Period of report

Sep 26, 2017

Accepted (ET)

Sep 28, 2017 · 7:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000939767

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Sep 26, 2017	M	33,333	$9.91	A	216,338	D
Common Stock^F2	Sep 26, 2017	S	33,333	$23.68	D	183,005	D
Common Stock	Sep 27, 2017	M	33,333	$9.91	A	216,338	D
Common Stock^F3	Sep 27, 2017	S	33,333	$23.94	D	183,005	D
Common Stock	Sep 28, 2017	M	33,334	$9.91	A	216,339	D
Common Stock^F4	Sep 28, 2017	S	33,334	$23.74	D	183,005	D
Common Stock^F5	holding	—	—		—	14,186	I	By 401(k)

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F6	$9.91	Sep 26, 2017	M	33,333	D	Dec 6, 2008	Dec 5, 2017	Common Stock	33,333	66,667	D
Option (right to buy)^F6	$9.91	Sep 27, 2017	M	33,333	D	Dec 6, 2008	Dec 5, 2017	Common Stock	33,333	33,334	D
Option (right to buy)^F6	$9.91	Sep 28, 2017	M	33,334	D	Dec 6, 2008	Dec 5, 2017	Common Stock	33,334	0	D

Explanation of responses

F1Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.66 to $23.80. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.70 to $24.22. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.70 to $23.76. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5Represents 14,186 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 26, 2017.
F6The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2011.